-+ 0.00%
-+ 0.00%
-+ 0.00%

CEREVANCE : TO MEET WITH FDA TO DISCUSS PATH TO POTENTIAL NEW DRUG APPLICATION FOR SOLENGEPRAS

Reuters·10/07/2026 12:04:39